5 Most Expensive Health Care Stocks You Should Worry About
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
GameStop Spikes Higher — Is Another Trip To The Moon On The Horizon?
GameStop Corporation (NYSE: GME) surged almost 13% at one point on Wednesday after rallying 8.5% on Tuesday.
Ford Breaks Bullishly From This Pattern, Charges Toward Resistance: Here Are The Levels To Watch
Ford Motor Company (NYSE: F) was popping up about 1.6% higher on Wednesday, in tandem with the S&P 500, which was trading about 0.5% higher in the afternoon after a volatile start.
Looking Into BTCS’s Recent Short Interest
BTCS's (NASDAQ:BTCS) short percent of float has fallen 9.33% since its last report. The company recently reported that it has 57 thousand shares sold short, which is 0.68% of all regular shares that are available for trading.
Peering Into Rayonier Adv Materials’s Recent Short Interest
Rayonier Adv Materials's (NYSE:RYAM) short percent of float has fallen 4.89% since its last report. The company recently reported that it has 1.30 million shares sold short, which is 2.53% of all regular shares that are available for trading.
Peering Into Sotera Health’s Recent Short Interest
Sotera Health's (NASDAQ:SHC) short percent of float has fallen 5.05% since its last report. The company recently reported that it has 7.58 million shares sold short, which is 7.71% of all regular shares that are available for trading.
Conagra Brands, Keurig Dr Pepper And These 2 Stocks Insiders Are Selling
The Nasdaq Composite gained by over 100 points on Tuesday. Investors, meanwhile, focused on some notable insider trades.
Cathie Wood Makes Whopping $12M Buy In Tesla Stock — Offloads Xpeng For 3rd Straight Day
Cathie Wood-led ARK Investment Management bought a whopping 100,982 shares of Tesla Inc (NASDAQ: TSLA) on Tuesday
Here’s What Microsoft Bulls Want To See To Spark A New Rally
Microsoft Corp (NASDAQ: MSFT) spiked up 1.84% higher on Tuesday but rejected Monday’s high-of-day as resistance and dropped to near flat.
Analyzing Vor Biopharma’s Short Interest
Vor Biopharma's (NASDAQ:VOR) short percent of float has fallen 58.58% since its last report. The company recently reported that it has 2.53 million shares sold short, which is 5.31% of all regular shares that are available for trading.